Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5280709
Max Phase: Preclinical
Molecular Formula: C38H53NO8
Molecular Weight: 651.84
Associated Items:
ID: ALA5280709
Max Phase: Preclinical
Molecular Formula: C38H53NO8
Molecular Weight: 651.84
Associated Items:
Canonical SMILES: CO[C@@]12Nc3cccc(CC4OC4(C)C)c3[C@]1(O)C[C@@H]1CC[C@@]3(O)[C@@]45O[C@@H]4[C@@H]4O[C@H](C=C(C)C)OC(C)(C)[C@H]4O[C@H]5CC[C@]3(C)[C@]12C
Standard InChI: InChI=1S/C38H53NO8/c1-20(2)17-26-44-28-29(32(5,6)46-26)43-24-14-15-33(7)34(8)22(13-16-36(33,41)37(24)30(28)47-37)19-35(40)27-21(18-25-31(3,4)45-25)11-10-12-23(27)39-38(34,35)42-9/h10-12,17,22,24-26,28-30,39-41H,13-16,18-19H2,1-9H3/t22-,24-,25?,26-,28+,29-,30+,33+,34-,35+,36-,37-,38+/m0/s1
Standard InChI Key: WSSPQHFLVBEQBI-FXWBJDMXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 651.84 | Molecular Weight (Monoisotopic): 651.3771 | AlogP: 5.10 | #Rotatable Bonds: 4 |
Polar Surface Area: 114.47 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.95 | CX Basic pKa: | CX LogP: 5.21 | CX LogD: 5.21 |
Aromatic Rings: 1 | Heavy Atoms: 47 | QED Weighted: 0.30 | Np Likeness Score: 1.73 |
1. Bhattacharjee P, Rutland N, Iyer MR.. (2022) Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential., 65 (24.0): [PMID:36473091] [10.1021/acs.jmedchem.2c01265] |
Source(1):